| Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ... New England Journal of Medicine 378 (5), 439-448, 2018 | 4968 | 2018 |
| Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data VHJ Van der Velden, G Cazzaniga, A Schrauder, J Hancock, P Bader, ... Leukemia 21 (4), 604-611, 2007 | 865 | 2007 |
| Phase I/phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia A von Stackelberg, F Locatelli, G Zugmaier, R Handgretinger, TM Trippett, ... Journal of Clinical Oncology 34 (36), 4381-4389, 2016 | 600 | 2016 |
| Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 51 (6), 786-792, 2016 | 573 | 2016 |
| Determinants of antileukemia effects of allogeneic NK cells W Leung, R Iyengar, V Turner, P Lang, P Bader, P Conn, D Niethammer, ... The Journal of Immunology 172 (1), 644-650, 2004 | 551 | 2004 |
| Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ... Bone marrow transplantation 50 (8), 1037-1056, 2015 | 481 | 2015 |
| Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 51 (7), 906-912, 2016 | 451 | 2016 |
| Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation E Gluckman, B Cappelli, F Bernaudin, M Labopin, F Volt, J Carreras, ... Blood, The Journal of the American Society of Hematology 129 (11), 1548-1556, 2017 | 444 | 2017 |
| Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM … P Bader, H Kreyenberg, GHR Henze, C Eckert, M Reising, A Willasch, ... Journal of Clinical Oncology 27 (3), 377-384, 2009 | 436 | 2009 |
| Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ... Bone marrow transplantation 52 (6), 811-817, 2017 | 435 | 2017 |
| Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial S Corbacioglu, S Cesaro, M Faraci, D Valteau-Couanet, B Gruhn, ... The Lancet 379 (9823), 1301-1309, 2012 | 413 | 2012 |
| Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 50 (6), 781-789, 2015 | 406 | 2015 |
| Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial F Locatelli, P Nöllke, M Zecca, E Korthof, E Lanino, C Peters, A Pession, ... Blood 105 (1), 410-419, 2005 | 390 | 2005 |
| Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 RF Duarte, M Labopin, P Bader, GW Basak, C Bonini, C Chabannon, ... Bone marrow transplantation 54 (10), 1525-1552, 2019 | 359 | 2019 |
| Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children R Handgretinger, T Klingebiel, P Lang, M Schumm, S Neu, A Geiselhart, ... Bone marrow transplantation 27 (8), 777-783, 2001 | 349 | 2001 |
| Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation … P Bader, H Kreyenberg, W Hoelle, G Dueckers, R Handgretinger, P Lang, ... Journal of clinical oncology 22 (9), 1696-1705, 2004 | 320 | 2004 |
| Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and … S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, JH Dalle, ... Bone marrow transplantation 53 (2), 138-145, 2018 | 315 | 2018 |
| How and when should we monitor chimerism after allogeneic stem cell transplantation? P Bader, D Niethammer, A Willasch, H Kreyenberg, T Klingebiel Bone marrow transplantation 35 (2), 107-119, 2005 | 300 | 2005 |
| Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 50 (4), 476-482, 2015 | 295 | 2015 |
| Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection H Einsele, H Hebart, C Kauffmann-Schneider, C Sinzger, G Jahn, P Bader, ... Bone marrow transplantation 25 (7), 757-763, 2000 | 289 | 2000 |
Locatelli FrancoUniversity of Pavia, Ospedale Bambino Gesù, Roma, Policlinico San MatteoDirección de correo verificada de opbg.net
